Dr Miura is a Genitourinary Medical Oncologist working as a staff doctor in the Department of Medical Oncology at Toranomon Hospital, Tokyo, Japan. He completed his M. D. Degree in 2002 and received the board certification of the Japanese Society of Medical Oncology (JSMO) and the Japanese Society of Hematology (JSH) in 2010. He dedicates his time to some collaborative clinical trials in Japan as a principal investigator. He is currently undertaking basic research training at the University of Texas, MD Anderson Cancer Center. The vision of Dr Miura is to provide the co-existence of more effective and less toxic treatments with a peaceful life for cancer patients. His research interests are identifying biomarkers, especially those that predict adverse events of targeted therapy along with immunotherapy for renal cell carcinoma.